Heres-Becerril SD

Idioma: Español
Referencias bibliográficas: 10
Paginas: 137-139
Archivo PDF: 158.29 Kb.

FRAGMENTO

El trasplante de órganos está limitado por la disponibilidad de donantes. Existe un marcado desequilibrio entre el número de órganos viables y el número de pacientes receptores. El donador vivo contribuye significativamente, en especial para el trasplante renal; sin embargo, la mayoría de los trasplantes utilizan órganos de donadores con muerte encefálica.

REFERENCIAS (EN ESTE ARTÍCULO)

1. McKeown DW, Bonser RS, Kellum JA. Management of the heartbeating brain-dead organ donor. Br J Anaesth. 2012;108:i96-i107.

2. Plurad DS, Bricker S, Neville A, Bongard F, Putnam B. Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors. Am J Surg. 2012;204:856-860.

3. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304:2620-2627.

4. Dupuis S, Amiel JA, Desgroseilliers M, et al. Corticosteroids in the management of brain-dead potential organ donors: a systematic review. Br J Anaesth. 2014;113:346-359.

5. Dhar R, Cotton C, Coleman J, et al. Comparison of high- and low-dose corticosteroid regimens for organ donor management. J Crit Care. 2013;28:111.e1-7.

6. Anderson TA, Bekker P, Vagefi PA. Anesthetic considerations in organ procurement surgery: a narrative review. Can J Anaesth. 2015;62-529-539.

7. Dhanani S, Shemie SD. Advancing the science of organ donor management. Crit Care. 2014;18:612.

8. Youn TS, Greer DM. Brain death and management of a potential organ donor in the intensive care unit. Crit Care Clin. 2014;30:813-831.

9. Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand. 2009;53:425-435.

10. Rech TH, Moraes RB, Crispim D, Czepielewski MA, Leitão CB. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation. 2013;95:966-974.